| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > 10 Fundamentals for Effective Meeting |
|
Subjects - 10 Fundamentals for Effective Meeting
Here are ten fundamental concepts that characterize an effective mee According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ting. Definition: A meeting is a business activity where select peo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ple gather to perform work that requires a team effort. A meeting, lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. like any business event, succeeds when it is preceded by planning,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe characterized by focus, governed by structure, and controlled by a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro budget. Three things guarantee an unproductive meeting: poor planni ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng, lack of appropriate
process, and hostile culture. Effective le easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ders attend to all of these to create an
effective meeting. Effec nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tive meetings require sharing control and making commitments. Short and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ meetings free people to work on the essential activities that repre ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sent the core
of their jobs. In contrast, long meetings prevent pe ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ople from working on critical
tasks such as planning, communicatin dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod g, and learning. The ultimate goals of every meeting are agreements cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin , decisions, or solutions.
Meetings held for other reasons seldom tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen roduce anything of value. Unprepared participants will spend their t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel time in the meeting preparing for the
meeting. It is better to sp ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust end a little time preparing for solutions than to spend a lot of tim y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e
fixing problems. Meetings are an investment of resources and ti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de me that should earn a profit. A meeting can be led from any chair i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip n the room. And if it’s your meeting, you want
it to be your chair tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Going Green Makes Good Business Sense
|